Home › Lymfoom

Lymfoom klinische studies rekruteren in de VS

142 studies voor Lymfoom rekruteren deelnemers op locaties doorheen de Verenigde Staten.

Steden met de meeste studies

• Houston, TX34 studies
• New York City, NY33 studies
• Boston, MA33 studies
• Washington, DC23 studies
• Baldwin Park, CA21 studies
• Chicago, IL20 studies
• Durham, NC17 studies
• St. Louis, MO15 studies
• Philadelphia, PA15 studies
• Cleveland, OH14 studies
• Edison, NJ12 studies
• Atlanta, GA12 studies
• Seattle, WA12 studies
• Columbus, OH11 studies
• Nashville, TN11 studies
• Miami, FL11 studies
• Rochester, MN11 studies
• Salt Lake City, UT11 studies
• Queens, NY10 studies
• Los Angeles, CA10 studies
• Pittsburgh, PA10 studies
• Dallas, TX10 studies
• Mountain View, CA9 studies
• Portland, OR9 studies
• Greenburgh, NY9 studies
• Denver, CO9 studies
• Milwaukee, WI9 studies
• East Norwalk, CT8 studies
• Staten Island, NY8 studies
• Aurora, CO8 studies
• Cincinnati, OH8 studies
• Birmingham, AL8 studies
• New Rochelle, NY7 studies
• San Antonio, TX7 studies
• Tampa, FL7 studies
• Omaha, NE7 studies
• Phoenix, AZ7 studies
• New Haven, CT7 studies
• Kansas City, MO6 studies
• Winston-Salem, NC6 studies

Per staat

• Alabama9 studies
• Arizona11 studies
• Arkansas3 studies
• Californië40 studies
• Colorado16 studies
• Connecticut7 studies
• District of Columbia7 studies
• Florida25 studies
• Georgia16 studies
• Illinois23 studies
• Indiana6 studies
• Iowa6 studies
• Kansas7 studies
• Kentucky5 studies
• Maryland21 studies
• Massachusetts33 studies
• Michigan12 studies
• Minnesota14 studies
• Missouri17 studies
• Nebraska7 studies
• New Jersey18 studies
• New York42 studies
• North Carolina22 studies
• Ohio29 studies
• Oklahoma4 studies
• Oregon9 studies
• Pennsylvania24 studies
• South Carolina4 studies
• Tennessee15 studies
• Texas45 studies
• Utah14 studies
• Virginia10 studies
• Washington12 studies
• Wisconsin12 studies

Recent bijgewerkte studies

Officiële studietekst (Engels)

Van ClinicalTrials.gov, gegevens opgehaald op 2 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.